Pelican-Cancer-Foundation-logos
Donate Now
Search
Pelican-Cancer-Foundation-logos

Dedicated to helping patients with bowel and liver cancer live well for longer

Donate Now
Search
  • Home
  • About us
    • About us
    • What we do
      • Our achievements
      • The Future
    • Who we are
      • Trustees
      • Our Team
      • Patrons
      • Annual Accounts
    • Partnerships
    • Vacancies
    • News
  • Education
    • Pelican OReCO
      • OReCO On-line Resources
      • OReCO Partners & Sponsors
      • Pelican OReCO Workshops
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
    • LARS
    • Sponsors
      • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Films
  • Research
    • MERCURY 3
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Previous Research Areas
      • Prostate Cancer Research
        • Prostate cancer
        • Focal therapy and HIFU research
        • MRI research for prostate cancer
        • Prostate cancer colloquiums
        • FORECAST
        • Trachtomap
        • Papers of interest
      • Bladder cancer research
        • Bladder cancer
        • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for research applicants
      • Peer Review Panel Terms of Reference
      • Research Review Panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Shares
      • In memory
    • Fundraise for us
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
    • Leave a Gift in your Will
    • Become a Corporate Partner
    • Trusts, Foundations & Philanthropy
    • Tell us your story
  • Contact us

Key papers – TIPTOP

February 12, 2019 by pelicanadmin

Editorial: Gleason score assignment is the sole responsibility of the pathologist Murali Varma, Dan Berney, Jon Oxley, Kiril Trpkov
Histopathology 2018;73:5-7.  https://onlinelibrary.wiley.com/doi/abs/10.1111/his.13472
J Clin Pathol 2018;71:874-878  https://jcp.bmj.com/content/71/10/874.abstract

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study Hashim UAhmedFRCSab* AhmedEl-Shater BosailyMBBChab* Louise CBrownPhDd* RhianGabePhDe ProfRichardKaplanFRCPd ProfMahesh KParmarDPhild  YolandaCollaco-MoraesPhDd KatieWardBScd Richard GHindleyFRCSf AlexFreemanFRCPathg Alex PKirkhamFRCRh RobertOldroydMAi  ChrisParkerFRCRc  ProfMarkEmbertonFRCSabPROMIS study group†

MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis Veeru Kasivisvanathan, M.R.C.S., Antti S. Rannikko, Ph.D., Marcelo Borghi, M.D., Valeria Panebianco, M.D., Lance A. Mynderse, M.D., Markku H. Vaarala, Ph.D., Alberto Briganti, Ph.D., Lars Budäus, M.D., Giles Hellawell, F.R.C.S.(Urol.), Richard G. Hindley, et al., for the PRECISION Study Group Collaborators*

A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging–Ultrasound Fusion and Visual Estimation in the Performance of MR-targeted Prostate Biopsy: The PROFUS Trial James S.Wysocka Andrew B.Rosenkrantzb William C.Huanga Michael D.Stifelmana HerbertLepora Fang-MingDengc  JonathanMelamedc  Samir S.Tanejaa
Eur Urol. 2018 Jul;74(1):48-54. doi: 10.1016/j.eururo.2018.03.007. Epub 2018 Mar 19.

Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What’s Next? Panebianco V1, Barchetti G2, Simone G3, Del Monte M4, Ciardi A4, Grompone MD4, Campa R4, Indino EL4, Barchetti F4, Sciarra A5, Leonardo C5, Gallucci M3, Catalano C6.

Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI‐transrectal ultrasonography (TRUS) fusion‐guided transperineal prostate biopsies as a validation tool Gabriele Gaziev, Karan Wadhwa, Tristan Barrett, Brendan C. Koo, Ferdia A. Gallagher, Eva Serrao, Julia Frey, Jonas Seidenader, Lina Carmona, Anne Warren.

Combination of prostate imaging reporting and data system (PI‐RADS) score and prostate‐specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients Satoshi Washino, Tomohisa Okochi, Kimitoshi Saito, Tsuzumi Konishi, Masaru Hirai, Yutaka Kobayashi, Tomoaki Miyagawa

Nuclear Magnetic Resonance Imaging of the Prostate H. Steyn, W. Smith  First published: December 1982  British Journal of Urology – Volume 54, Issue 6

NMR scanning of the pelvis: initial experience with a 0.3 T system PJ Bryan, HE Butler, JP LiPuma, Haaga, JR … Show all

MR imaging of the prostate gland: normal anatomy H Hricak, GC Dooms, JE McNeal, AS Mark.

Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting LouiseDickinsonabc Hashim U.Ahmedab ClareAllend  Jelle O.Barentsze BrendanCareyf Jurgen J.Futterere  Stijn W.Heijminke Peter J.Hosking AlexKirkhamd Anwar R.Padhanih RajPersadi  PhilippePuechj  ShonitPunwanid Aslam S.Sohaibk BertrandTomball ArnauldVillersm Janvan der Meulencn  MarkEmbertonabc

DWI of Prostate Cancer: Optimal -Value in Clinical Practice Guglielmo Manenti,1 Marco Nezzo,1 Fabrizio Chegai,1 Erald Vasili,1Elena Bonanno,2 and Giovanni Simonetti1

The impact of computed high b-value images on the diagnostic accuracy of DWI for prostate cancer: A receiver operating characteristics analysis Peigang Ning, Dapeng Shi, Geoffrey A. Sonn, Shreyas S. Vasanawala, Andreas M. Loening, Pejman Ghanouni, Piotr Obara, Lewis K. Shin, Richard E. Fan, Brian A. Hargreaves & Bruce L. Daniel  Journal of Magnetic Resonance Imaging Volume 36, Issue 1

Clinical utility of apparent diffusion coefficient values obtained using high b‐value when diagnosing prostate cancer using 3 tesla MRI: Comparison between ultra‐high b‐value (2000 s/mm2) and standard high b‐value (1000 s/mm2) Kazuhiro Kitajima MD, PhD, Satoru Takahashi MD, PhD, Yoshiko Ueno MD, Takeshi Yoshikawa MD, PhD, Yoshiharu Ohno MD, PhD, Makoto Obara PhD… See all authors 

National implementation of multi‐parametric magnetic resonance imaging for prostate cancer detection – recommendations from a UK consensus meeting Mrishta Brizmohun Appayya, 1 Jim Adshead, 2 Hashim U. Ahmed, 3 , 4Clare Allen, 5 Alan Bainbridge, 6 Tristan Barrett, 7 Francesco Giganti, 3 , 5John Graham, 8 Phil Haslam, 9 Edward W. Johnston, 1 , 5Christof Kastner, 10 Alexander P.S. Kirkham, 5 Alexandra Lipton, 11Alan McNeill, 12 Larissa Moniz, 13 Caroline M. Moore, 4 , 14 Ghulam Nabi, 15 Anwar R. Padhani, 16 Chris Parker, 17 Amit Patel, 18Jacqueline Pursey, 19 Jonathan Richenberg, 20  John Staffurth,  21Jan van der Meulen, 22 Darren Walls, 23 and Shonit Punwani 1 , 5

Eur Radiol. 2012 Apr;22(4):746-57. doi: 10.1007/s00330-011-2377-y. Epub 2012 Feb 10.

ESUR prostate MR guidelines 2012 Barentsz JO1, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Fütterer JJ; European Society of Urogenital Radiology.

PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2Jeffrey C.Weinreba† Jelle O.Barentszb† Peter L.Choykec FrancoisCornudd Masoom A.Haidere Katarzyna J.Macuraf DanielMargolisg Mitchell D.Schnallh FainaShterni Clare M.Tempanyj Harriet C.Thoenyk SadnaVermal

Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use Jelle O. Barentsz. Correspondence information about the author Jelle O. Barentsz, Jeffrey C. Weinreb, Sadhna Verma, Harriet C. Thoeny, Clare M. Tempany, Faina Shtern, Anwar R. Padhani, Daniel Margolis, Katarzyna J. Macura, Masoom A. Haider, Francois Cornud, Peter L. Choyke  Journal of Magnetic Resonance Imaging Volume 48, Issue 2

All over the map: An interobserver agreement study of tumor location based on the PI-RADSv2 sector map Matthew D. Greer MD, Joanna H. Shih PhD, Tristan Barrett MD, Sandra Bednarova MD, Ismail Kabakus MD, Yan Mee Law MD, Haytham Shebel MD, Maria J. Merino MD… See all authors   First published: 17 January 2018

Prostate MRI: Who, when, and how? Report from a UK consensus meeting A.P.S.Kirkhama P.Haslamb J.Y.Keaniec I.McCaffertyd A.R.Padhanie S.Punwania J.Richenbergf G.Rottenbergg A.Sohaibh P.Thompsonf L.W.Turnbulli L.Kurbanj A.Sahdevk   R.Clementsl B.M.Careym C.Allena

Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations—A Report of a European School of Oncology Task Force Caroline M.Mooreab‡ FrancescoGiganticd‡ PeterAlbertsene ClareAllenc ChrisBangmaf AlbertoBrigantig PeterCarrollh MasoomHaider iVeeruKasivisvanathanab AlexKirkhamc LaurenceKlotzj AdilOuzzanek   Anwar R.Padhanil ValeriaPanebiancom PeterPinton PhilippePuecho AnttiRannikkop RaphaeleRenard-Pennaq IvoSchootsx

Sequential prostate MRI reporting in men on active surveillance: initial experience of a dedicated PRECISE software program FrancescoGigantiab ClareAllena Jonathan W.Piperc DavidMirandoc ArmandoStabilebd eShonitPunwaniaf AlexKirkhama MarkEmbertonbe Caroline M.Moorebe

A Prospective, Blinded Comparison of Magnetic Resonance (MR) Imaging–Ultrasound Fusion and Visual Estimation in the Performance of MR-targeted Prostate Biopsy: The PROFUS Trial

European Urology Volume 66, Issue 2, August 2014, Pages 343-351 James S.Wysocka Andrew B.Rosenkrantzb William C.Huanga Michael D.Stifelmana HerbertLepora Fang-MingDengc JonathanMelamedc Samir S.Tanejaa  BJU International    Volume 117, Issue 1

Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI‐transrectal ultrasonography (TRUS) fusion‐guided transperineal prostate biopsies as a validation tool Gabriele Gaziev, Karan Wadhwa, Tristan Barrett, Brendan C. Koo, Ferdia A. Gallagher, Eva Serrao, Julia Frey, Jonas Seidenader, Lina Carmona, Anne Warren… See all authors  First published: 07 August 2014 BJU International     Volume 119, Issue 2

Combination of prostate imaging reporting and data system (PI‐RADS) score and prostate‐specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patientsSatoshi Washino, Tomohisa Okochi, Kimitoshi Saito, Tsuzumi Konishi, Masaru Hirai, Yutaka Kobayashi, Tomoaki Miyagawa   First published: 02 March 2016

VANGUARDS:  ‘Each vanguard will take a lead on the development of new care models which will act as the blueprints for the NHS moving forward and the inspiration to the rest of the health and care system’(www.england.nhs.uk/ourwork/futurenhs/new-care-models)

 

 

Filed Under: Uncategorized

Stay in touch

Sign up to hear from us
Donate Now

© 2023 Pelican Cancer Foundation - all rights reserved

  Registered Charity Number: 1141911 -  Privacy Policy